PDF(Pubmed)
Abstract：
Interest in psychedelics is increasing due to the potential for improved mental health and quality of life. However, adverse effects on mental health are still a concern. Personality traits have been suggested to both influence the psychedelic experience and mental health, and even be changed by psychedelic use. The present study describes for the first time a national sample of Swedish psychedelic users (n = 400) compared to a sex and age-matched control-group of non-users (n = 400) regarding mental health variables (depression, insomnia, problematic alcohol and drug use, and dissociation) and personality (Big Five). Data was collected in an online survey including individuals from 16 years of age who had at least one psychedelic experience. The main results reported psychedelic users as less depressed (Patient Health Questionnaire-9; PHQ-9) (d = - 0.29) and having more use of drugs (Drug Use Disorders Identification Test; DUDIT) (d = 1.27). In the Big Five personality traits, openness differed notably (d = 1.72), and the between-group effects in PHQ-9 were explained by lower neuroticism. Our findings reveal that psychedelic users report less depression and higher drug use, and this is partly due to personality traits. These results have implications on how we view psychedelic users and the use of psychedelic drugs.
摘要：
由于改善心理健康和生活质量的潜力，人们对迷幻药的兴趣正在增加。然而,对心理健康的不利影响仍然令人担忧。人格特质被认为会影响迷幻体验和心理健康，甚至被迷幻的使用所改变。本研究首次描述了瑞典迷幻使用者的国家样本（n=400）与性别和年龄匹配的非使用者对照组（n=400）有关心理健康变量（抑郁症，失眠,有问题的酒精和药物使用，和分离)和个性(五大)。数据是在一项在线调查中收集的，其中包括16岁以上至少有一次迷幻经历的人。主要结果显示迷幻药使用者的抑郁程度较低（患者健康问卷-9；PHQ-9）（d=-0.29），并且使用药物更多（药物使用障碍鉴定测试；DUDIT）（d=1.27）。在五大人格特质中，开放度明显不同(d=1.72)，PHQ-9的组间效应由较低的神经质解释。我们的研究结果表明，迷幻药使用者报告的抑郁程度较低，药物使用率较高，这部分是由于人格特质。这些结果对我们如何看待迷幻药使用者和迷幻药的使用有影响。
